Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 525

1.

Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.

Wang F, Shen Y, Xu X, Lv L, Li Y, Liu J, Li M, Guo A, Guo S, Jin F.

Int J Pharm. 2013 Nov 1;456(1):101-12. doi: 10.1016/j.ijpharm.2013.08.008.

PMID:
23968782
2.

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.

Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, Préat V.

Eur J Pharm Biopharm. 2009 Oct;73(2):230-8. doi: 10.1016/j.ejpb.2009.06.015.

PMID:
19577643
3.

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

Gong C, Xie Y, Wu Q, Wang Y, Deng S, Xiong D, Liu L, Xiang M, Qian Z, Wei Y.

Nanoscale. 2012 Sep 28;4(19):6004-17. doi: 10.1039/c2nr31517c.

PMID:
22910790
4.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020.

PMID:
20056123
5.

Polysorbate 80 coated poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) micelles for paclitaxel delivery.

Wang Y, Wang C, Gong C, Wang Y, Guo G, Luo F, Qian Z.

Int J Pharm. 2012 Sep 15;434(1-2):1-8. doi: 10.1016/j.ijpharm.2012.05.015.

PMID:
22609127
6.

Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.

Wang Y, Li Y, Zhang L, Fang X.

Arch Pharm Res. 2008 Apr;31(4):530-8. doi: 10.1007/s12272-001-1189-2.

PMID:
18449513
7.

PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.

Chu B, Qu Y, Huang Y, Zhang L, Chen X, Long C, He Y, Ou C, Qian Z.

Int J Pharm. 2016 Mar 16;500(1-2):345-59. doi: 10.1016/j.ijpharm.2016.01.030.

PMID:
26794876
8.

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Jiang C, Wang H, Zhang X, Sun Z, Wang F, Cheng J, Xie H, Yu B, Zhou L.

Int J Pharm. 2014 Nov 20;475(1-2):60-8. doi: 10.1016/j.ijpharm.2014.08.037.

PMID:
25152167
9.
10.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.

Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.

Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032.

PMID:
24858391
11.

Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.

Wang Y, Hao J, Li Y, Zhang Z, Sha X, Han L, Fang X.

Biomaterials. 2012 Jun;33(18):4741-51. doi: 10.1016/j.biomaterials.2012.03.013.

PMID:
22445254
12.

Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.

Wang F, Zhang D, Zhang Q, Guo S, Zheng D, Hao L, Guo H, Li C.

J Drug Target. 2013 Feb;21(2):137-45. doi: 10.3109/1061186X.2012.731067.

PMID:
23046502
13.
14.

Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.

Gupta R, Shea J, Scafe C, Shurlygina A, Rapoport N.

J Control Release. 2015 Aug 28;212:70-7. doi: 10.1016/j.jconrel.2015.06.019.

PMID:
26091919
15.

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.

Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.

Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005.

PMID:
20934500
16.

Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.

Yang R, Meng F, Ma S, Huang F, Liu H, Zhong Z.

Biomacromolecules. 2011 Aug 8;12(8):3047-55. doi: 10.1021/bm2006856.

PMID:
21726090
17.

Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.

Zhang Y, Huang Y, Zhao W, Lu J, Zhang P, Zhang X, Li J, Gao X, Venkataramanan R, Li S.

AAPS J. 2014 Nov;16(6):1282-91. doi: 10.1208/s12248-014-9651-2.

18.

Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.

Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.

Biomaterials. 2008 Mar;29(9):1233-41.

PMID:
18093646
19.

Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.

Huang X, Zhang Y, Yin G, Pu X, Liao X, Huang Z, Chen X, Yao Y.

J Mater Sci Mater Med. 2015 Feb;26(2):95. doi: 10.1007/s10856-015-5447-x.

PMID:
25649516
20.

PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.

Jiang X, Xin H, Sha X, Gu J, Jiang Y, Law K, Chen Y, Chen L, Wang X, Fang X.

Int J Pharm. 2011 Nov 28;420(2):385-94. doi: 10.1016/j.ijpharm.2011.08.052.

PMID:
21920419
Items per page

Supplemental Content

Support Center